• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发缓解型多发性硬化早期的威胁性疾病认知及相关因素

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.

作者信息

Gómez-Ballesteros Rocío, Sainz de la Maza Susana, Borges Mónica, Martín-Martínez Jesús, Sotoca Javier, Alonso Ana, Caminero Ana B, Borrega Laura, Sánchez-Menoyo José L, Barrero-Hernández Francisco J, Calles Carmen, Brieva Luis, Blasco-Quílez María R, Dotor García-Soto Julio, Rodríguez-Regal Ana, Navarro-Cantó Laura, Agüera Eduardo, Garcés-Redondo Moisés, Carmona Olga, Gabaldón-Torres Laura, Forero Lucía, Hervás Mariona, Castillo-Triviño Tamara, Maurino Jorge

机构信息

Medical Department, Roche Farma, Madrid, Spain.

Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

出版信息

Front Psychiatry. 2025 Jul 8;16:1565150. doi: 10.3389/fpsyt.2025.1565150. eCollection 2025.

DOI:
10.3389/fpsyt.2025.1565150
PMID:40698047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12279862/
Abstract

BACKGROUND

Multiple sclerosis is one of the most common causes of neurological disability in young adults, with major consequences for their future lives. Patients with early-stage relapsing-remitting multiple sclerosis (RRMS) experience uncertainty and intense emotions as the diagnosis is disclosed. Illness perception at this point can influence levels of adjustment, coping strategies, treatment adherence, and well-being of the patient. However, there is limited information on patient illness perception surrounding the diagnosis.

OBJECTIVE

The aim of this study was to assess illness perception and associated factors in early-stage RRMS patients.

METHODS

A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration of ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0-5.5 were included. The Brief-Illness Perception Questionnaire (B-IPQ) was used to assess the patients' cognitive and emotional representations of their illness. Different patient-reported measures were used to gather information on pain, fatigue, mood/anxiety, quality of life, symptom severity, feelings of hopelessness, perception of stigma, cognition, hand dexterity, gait, and workplace difficulties. A multivariate logistic regression analysis was performed to assess the association between the patients' illness perception and demographic and clinical characteristics, as well as patient-reported outcomes.

RESULTS

A total of 189 patients were included (mean age: 36.1 ± 9.4 years, 71.4% females, mean disease duration: 1.4 ± 0.8 years). The median EDSS score was 1.0 (interquartile range: 0.0-2.0). A total of 36.5% of the patients (n=69/189) had a moderate-to-high threatening illness perception, and 45.5% thought that their disease was caused by psychological factors. Higher EDSS scores, symptom severity, poorer psychological quality of life, perception of stigma, and greater hopelessness were predictors of moderate-to-high threatening illness perception.

CONCLUSIONS

Threatening illness perceptions are common among patients with early-stage RRMS. Identifying these beliefs and their associated factors, and establishing individualized interventions, may help patients deal with their condition.

摘要

背景

多发性硬化症是年轻成年人神经功能残疾最常见的病因之一,对他们的未来生活有重大影响。早期复发缓解型多发性硬化症(RRMS)患者在得知诊断结果时会经历不确定性和强烈情绪。此时的疾病认知会影响患者的适应水平、应对策略、治疗依从性和幸福感。然而,关于患者在诊断前后的疾病认知信息有限。

目的

本研究旨在评估早期RRMS患者的疾病认知及相关因素。

方法

开展一项多中心、非干预性研究。纳入诊断为RRMS、病程≤3年且扩展残疾状态量表(EDSS)评分为0 - 5.5的成年患者。采用简明疾病认知问卷(B - IPQ)评估患者对疾病的认知和情感表征。使用不同的患者报告测量方法收集有关疼痛、疲劳、情绪/焦虑、生活质量、症状严重程度、绝望感、耻辱感、认知、手部灵活性、步态和工作场所困难等方面的信息。进行多因素逻辑回归分析,以评估患者的疾病认知与人口统计学和临床特征以及患者报告结局之间的关联。

结果

共纳入189例患者(平均年龄:36.1±9.4岁,71.4%为女性,平均病程:1.4±0.8年)。EDSS评分中位数为1.0(四分位间距:0.0 - 2.0)。共有36.5%的患者(n = 69/189)具有中度至高度的威胁性疾病认知,45.5%的患者认为其疾病是由心理因素引起的。较高的EDSS评分、症状严重程度、较差的心理生活质量、耻辱感和更强的绝望感是中度至高度威胁性疾病认知的预测因素。

结论

在早期RRMS患者中,威胁性疾病认知很常见。识别这些信念及其相关因素,并制定个性化干预措施,可能有助于患者应对病情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b183/12279862/79eb656bca8a/fpsyt-16-1565150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b183/12279862/57127a914ff7/fpsyt-16-1565150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b183/12279862/79eb656bca8a/fpsyt-16-1565150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b183/12279862/57127a914ff7/fpsyt-16-1565150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b183/12279862/79eb656bca8a/fpsyt-16-1565150-g002.jpg

相似文献

1
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.复发缓解型多发性硬化早期的威胁性疾病认知及相关因素
Front Psychiatry. 2025 Jul 8;16:1565150. doi: 10.3389/fpsyt.2025.1565150. eCollection 2025.
2
Rituximab for relapsing-remitting multiple sclerosis.利妥昔单抗用于复发缓解型多发性硬化症。
Cochrane Database Syst Rev. 2013 Dec 6;2013(12):CD009130. doi: 10.1002/14651858.CD009130.pub3.
3
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.用于多发性硬化症的免疫调节剂和免疫抑制剂:一项网状Meta分析
Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD008933. doi: 10.1002/14651858.CD008933.pub2.
4
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.免疫调节剂和免疫抑制剂治疗复发缓解型多发性硬化症的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jan 4;1(1):CD011381. doi: 10.1002/14651858.CD011381.pub3.
5
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.用于复发缓解型多发性硬化症的免疫调节剂和免疫抑制剂:一项网状荟萃分析。
Cochrane Database Syst Rev. 2015 Sep 18;2015(9):CD011381. doi: 10.1002/14651858.CD011381.pub2.
6
Teriflunomide for multiple sclerosis.特立氟胺用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2016 Mar 22;3(3):CD009882. doi: 10.1002/14651858.CD009882.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
9
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
How Does Shame Relate to Clinical and Psychosocial Outcomes in Knee Osteoarthritis?羞耻感与膝关节骨关节炎的临床及心理社会结局有何关联?
Clin Orthop Relat Res. 2025 Apr 1;483(4):558-570. doi: 10.1097/CORR.0000000000003329. Epub 2024 Dec 3.

本文引用的文献

1
Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections.多发性硬化症的流行病学:全球、区域、国家和次国家层面的估计及未来预测。
J Epidemiol Glob Health. 2025 Feb 10;15(1):21. doi: 10.1007/s44197-025-00353-6.
2
Unveiling preferences in multiple sclerosis care: insights from an Italian discrete-choice experiment with patients and healthcare professionals.揭示多发性硬化症护理中的偏好:来自一项针对患者和医护人员的意大利离散选择实验的见解。
J Neurol. 2024 Dec 12;272(1):27. doi: 10.1007/s00415-024-12725-2.
3
Suicidal ideation in the year following diagnosis of relapsing-remitting multiple sclerosis: A longitudinal perspective.
多发性硬化症复发缓解型诊断后一年内的自杀意念:纵向观察。
Mult Scler Relat Disord. 2024 Nov;91:105904. doi: 10.1016/j.msard.2024.105904. Epub 2024 Sep 23.
4
Importance of Coping Strategies on Quality of Life in People with Multiple Sclerosis: A Systematic Review.应对策略对多发性硬化症患者生活质量的重要性:一项系统综述。
J Clin Med. 2024 Sep 18;13(18):5505. doi: 10.3390/jcm13185505.
5
Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.中期复发缓解型多发性硬化症患者的疾病相关不确定性感知。
Mult Scler Relat Disord. 2024 Nov;91:105861. doi: 10.1016/j.msard.2024.105861. Epub 2024 Sep 3.
6
Cognitive progression independent of relapse in multiple sclerosis.多发性硬化症认知进展与复发无关。
Mult Scler. 2024 Oct;30(11-12):1468-1478. doi: 10.1177/13524585241256540. Epub 2024 Aug 28.
7
The Impact of Social Cognition Deficits on Quality of Life in Multiple Sclerosis: A Scoping Review.社会认知缺陷对多发性硬化症患者生活质量的影响:一项范围综述
Brain Sci. 2024 Jul 11;14(7):691. doi: 10.3390/brainsci14070691.
8
A systematic review to explore patients' MS knowledge and MS risk knowledge.一项系统综述,旨在探索患者对多发性硬化症的认知和多发性硬化症风险的认知。
Neurol Sci. 2024 Sep;45(9):4185-4195. doi: 10.1007/s10072-024-07541-5. Epub 2024 May 3.
9
Design recommendations for studies that evaluate multiple sclerosis fatigue interventions.评估多发性硬化症疲劳干预措施的研究设计建议。
Front Psychiatry. 2024 Jan 10;14:1287344. doi: 10.3389/fpsyt.2023.1287344. eCollection 2023.
10
Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症复发的相关性和轨迹。
Neurol Sci. 2024 May;45(5):2181-2189. doi: 10.1007/s10072-023-07155-3. Epub 2023 Nov 17.